PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35444660-10	2022	These results suggest that CLV3 dAb can be potentially used as an anti-PD-L1 inhibitor for cancer immunotherapy.	3,3'-Diaminobenzidine	32-35	CD274 antigen	Mus musculus	71-76